Matches in SemOpenAlex for { <https://semopenalex.org/work/W2560713160> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2560713160 endingPage "393" @default.
- W2560713160 startingPage "388" @default.
- W2560713160 abstract "Background: The introduction of anti–tumor necrosis factor α (anti-TNFα) drugs has improved the clinical outcomes in rheumatoid arthritis (RA) and ankylosing spondylitis (AS). However, these drugs may cause adverse effects that motivate a change in or discontinuation of the treatment. Objective: To evaluate the causes of discontinuation or changes in the dosage regimen in a cohort of patients with RA and AS treated with infliximab, adalimumab, etanercept, and golimumab under clinical practice conditions. Methods: This was a retrospective observational study that included patients with RA or AS treated with anti-TNFα drugs between 2008 and 2013. Changes in the dosage regimen, reasons for treatment discontinuation, and adverse effects were recorded and analyzed. Time to discontinuation was estimated using Kaplan-Meier survival analysis. Results: A total of 123 patients with RA and 93 patients with AS were treated with anti-TNFα therapy. During the study, 55.3% of RA patients and 41.7% of AS patients had stopped the treatment. The most frequent changes were modifications in the dosing, and the most frequent adverse effects were reactions after the infusion or injection (53.8% and 66.7% in RA and AS, respectively). Drug survival of etanercept in RA (67.9%) is greater than for adalimumab and infliximab, whereas drug survival of infliximab in AS (70.0%) is greater than for etanercept and adalimumab at 5 years, although there were no significant differences ( P = 0.098 in RA and 0.194 in AS). Conclusions: The main cause of discontinuation of anti-TNFα is therapeutic failure in both diseases. Etanercept and infliximab have the best survival rates in RA and AS, respectively." @default.
- W2560713160 created "2016-12-16" @default.
- W2560713160 creator A5018913399 @default.
- W2560713160 creator A5019812476 @default.
- W2560713160 creator A5025178396 @default.
- W2560713160 creator A5032336123 @default.
- W2560713160 creator A5040803325 @default.
- W2560713160 creator A5054299234 @default.
- W2560713160 creator A5066620675 @default.
- W2560713160 creator A5076543091 @default.
- W2560713160 creator A5084550508 @default.
- W2560713160 date "2016-12-05" @default.
- W2560713160 modified "2023-09-27" @default.
- W2560713160 title "Reasons for Discontinuation and Adverse Effects of TNFα Inhibitors in a Cohort of Patients With Rheumatoid Arthritis and Ankylosing Spondylitis" @default.
- W2560713160 cites W1858749428 @default.
- W2560713160 cites W1969917809 @default.
- W2560713160 cites W1988532712 @default.
- W2560713160 cites W2002523668 @default.
- W2560713160 cites W2021153631 @default.
- W2560713160 cites W2033528121 @default.
- W2560713160 cites W2111965497 @default.
- W2560713160 cites W2124227426 @default.
- W2560713160 cites W2128775174 @default.
- W2560713160 cites W2133003110 @default.
- W2560713160 cites W2474501043 @default.
- W2560713160 cites W3022980932 @default.
- W2560713160 cites W4211172841 @default.
- W2560713160 cites W48743570 @default.
- W2560713160 doi "https://doi.org/10.1177/1060028016682330" @default.
- W2560713160 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27920336" @default.
- W2560713160 hasPublicationYear "2016" @default.
- W2560713160 type Work @default.
- W2560713160 sameAs 2560713160 @default.
- W2560713160 citedByCount "12" @default.
- W2560713160 countsByYear W25607131602019 @default.
- W2560713160 countsByYear W25607131602020 @default.
- W2560713160 countsByYear W25607131602021 @default.
- W2560713160 countsByYear W25607131602022 @default.
- W2560713160 crossrefType "journal-article" @default.
- W2560713160 hasAuthorship W2560713160A5018913399 @default.
- W2560713160 hasAuthorship W2560713160A5019812476 @default.
- W2560713160 hasAuthorship W2560713160A5025178396 @default.
- W2560713160 hasAuthorship W2560713160A5032336123 @default.
- W2560713160 hasAuthorship W2560713160A5040803325 @default.
- W2560713160 hasAuthorship W2560713160A5054299234 @default.
- W2560713160 hasAuthorship W2560713160A5066620675 @default.
- W2560713160 hasAuthorship W2560713160A5076543091 @default.
- W2560713160 hasAuthorship W2560713160A5084550508 @default.
- W2560713160 hasConcept C126322002 @default.
- W2560713160 hasConcept C141071460 @default.
- W2560713160 hasConcept C167135981 @default.
- W2560713160 hasConcept C17991360 @default.
- W2560713160 hasConcept C197934379 @default.
- W2560713160 hasConcept C2777138892 @default.
- W2560713160 hasConcept C2777226972 @default.
- W2560713160 hasConcept C2777402515 @default.
- W2560713160 hasConcept C2777575956 @default.
- W2560713160 hasConcept C2778715236 @default.
- W2560713160 hasConcept C2779722408 @default.
- W2560713160 hasConcept C2780132546 @default.
- W2560713160 hasConcept C2781290027 @default.
- W2560713160 hasConcept C2781413609 @default.
- W2560713160 hasConcept C71924100 @default.
- W2560713160 hasConceptScore W2560713160C126322002 @default.
- W2560713160 hasConceptScore W2560713160C141071460 @default.
- W2560713160 hasConceptScore W2560713160C167135981 @default.
- W2560713160 hasConceptScore W2560713160C17991360 @default.
- W2560713160 hasConceptScore W2560713160C197934379 @default.
- W2560713160 hasConceptScore W2560713160C2777138892 @default.
- W2560713160 hasConceptScore W2560713160C2777226972 @default.
- W2560713160 hasConceptScore W2560713160C2777402515 @default.
- W2560713160 hasConceptScore W2560713160C2777575956 @default.
- W2560713160 hasConceptScore W2560713160C2778715236 @default.
- W2560713160 hasConceptScore W2560713160C2779722408 @default.
- W2560713160 hasConceptScore W2560713160C2780132546 @default.
- W2560713160 hasConceptScore W2560713160C2781290027 @default.
- W2560713160 hasConceptScore W2560713160C2781413609 @default.
- W2560713160 hasConceptScore W2560713160C71924100 @default.
- W2560713160 hasIssue "5" @default.
- W2560713160 hasLocation W25607131601 @default.
- W2560713160 hasLocation W25607131602 @default.
- W2560713160 hasOpenAccess W2560713160 @default.
- W2560713160 hasPrimaryLocation W25607131601 @default.
- W2560713160 hasRelatedWork W1491634525 @default.
- W2560713160 hasRelatedWork W2015993259 @default.
- W2560713160 hasRelatedWork W2038285281 @default.
- W2560713160 hasRelatedWork W2039662997 @default.
- W2560713160 hasRelatedWork W2050121444 @default.
- W2560713160 hasRelatedWork W2320241810 @default.
- W2560713160 hasRelatedWork W2327054863 @default.
- W2560713160 hasRelatedWork W2390905470 @default.
- W2560713160 hasRelatedWork W2898641256 @default.
- W2560713160 hasRelatedWork W4283710071 @default.
- W2560713160 hasVolume "51" @default.
- W2560713160 isParatext "false" @default.
- W2560713160 isRetracted "false" @default.
- W2560713160 magId "2560713160" @default.
- W2560713160 workType "article" @default.